Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ackerman

Showing results (431-440 of 1,428) with videos related to

Pageof 143
Sort By:
Physiological Genomics|November 28, 2002
A common human SCN5A polymorphism modifies expression of an arrhythmia causing mutationBin Ye, Carmen R Valdivia, Michael J Ackerman, et al.
The Journal of Biological Chemistry|July 27, 2005
Functional consequences of hypertrophic and dilated cardiomyopathy-causing mutations in alpha-tropomyosinAudrey N Chang, Keita Harada, Michael J Ackerman, et al.
Blood|August 10, 1999
C/EBPbeta and GATA-1 synergistically regulate activity of the eosinophil granule major basic protein promoter: implication for C/EBPbeta activity in eosinophil gene expressionY Yamaguchi, H Nishio, K Kishi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1996
Eosinophil-fibroblast interactions. Granule major basic protein interacts with IL-1 and transforming growth factor-beta in the stimulation of lung fibroblast IL-6-type cytokine productionC L Rochester, S J Ackerman, T Zheng, et al.
The Biochemical Journal|September 15, 1992
Quantification of the accumulation and degradation of beta-very-low-density lipoproteins in vivo using a 19F-containing residualizing label and n.m.r. spectroscopyL A Meeh, J J Ackerman, S R Thorpe, et al.
Heart Rhythm|December 20, 2005
Cost-effectiveness analysis of genetic testing for familial long QT syndrome in symptomatic index casesKathryn A Phillips, Michael J Ackerman, Julie Sakowski, et al.
Heart Rhythm|March 4, 2008
Suppression of atrial fibrillation with mexiletine pharmacotherapy in a young woman with type 1 long QT syndromeMalek El Yaman, James Perry, Jonathan C Makielski, et al.
Circulation. Genomic and Precision Medicine|April 19, 2021
Clinical Impact of Secondary Risk Factors in <i>TTN</i>-Mediated Dilated CardiomyopathyJohn R Giudicessi, Sanskriti Shrivastava, Michael J Ackerman, et al.
Congenital Heart Disease|April 29, 2015
Breath Holding Spells in Children with Long QT SyndromeJeffrey A Robinson, J Martijn Bos, Susan P Etheridge, et al.
Blood|January 15, 1998
Forced GATA-1 expression in the murine myeloid cell line M1: induction of c-Mpl expression and megakaryocytic/erythroid differentiationY Yamaguchi, L I Zon, S J Ackerman, et al.
Pageof 143

Showing results (431-440 of 1,428) with videos related to

Sort By:
Pageof 143
Physiological Genomics|November 28, 2002
A common human SCN5A polymorphism modifies expression of an arrhythmia causing mutationBin Ye, Carmen R Valdivia, Michael J Ackerman, et al.
The Journal of Biological Chemistry|July 27, 2005
Functional consequences of hypertrophic and dilated cardiomyopathy-causing mutations in alpha-tropomyosinAudrey N Chang, Keita Harada, Michael J Ackerman, et al.
Blood|August 10, 1999
C/EBPbeta and GATA-1 synergistically regulate activity of the eosinophil granule major basic protein promoter: implication for C/EBPbeta activity in eosinophil gene expressionY Yamaguchi, H Nishio, K Kishi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1996
Eosinophil-fibroblast interactions. Granule major basic protein interacts with IL-1 and transforming growth factor-beta in the stimulation of lung fibroblast IL-6-type cytokine productionC L Rochester, S J Ackerman, T Zheng, et al.
The Biochemical Journal|September 15, 1992
Quantification of the accumulation and degradation of beta-very-low-density lipoproteins in vivo using a 19F-containing residualizing label and n.m.r. spectroscopyL A Meeh, J J Ackerman, S R Thorpe, et al.
Heart Rhythm|December 20, 2005
Cost-effectiveness analysis of genetic testing for familial long QT syndrome in symptomatic index casesKathryn A Phillips, Michael J Ackerman, Julie Sakowski, et al.
Heart Rhythm|March 4, 2008
Suppression of atrial fibrillation with mexiletine pharmacotherapy in a young woman with type 1 long QT syndromeMalek El Yaman, James Perry, Jonathan C Makielski, et al.
Circulation. Genomic and Precision Medicine|April 19, 2021
Clinical Impact of Secondary Risk Factors in <i>TTN</i>-Mediated Dilated CardiomyopathyJohn R Giudicessi, Sanskriti Shrivastava, Michael J Ackerman, et al.
Congenital Heart Disease|April 29, 2015
Breath Holding Spells in Children with Long QT SyndromeJeffrey A Robinson, J Martijn Bos, Susan P Etheridge, et al.
Blood|January 15, 1998
Forced GATA-1 expression in the murine myeloid cell line M1: induction of c-Mpl expression and megakaryocytic/erythroid differentiationY Yamaguchi, L I Zon, S J Ackerman, et al.
Pageof 143